Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
By Patrick Wingrove, Reuters
The FDA warned another Indian facility for widespread data integrity failures, inadequate manufacturing and cleaning validation, insufficient microbiological testing, and inaccurate drug listings
The study tested once-weekly subcutaneous doses from 0.5 mg up to 12 mg and showed a clear dose-response signal
Optimization of bivalent glutathione S-transferase inhibitors by combinatorial linker [PMID: 16802828] Laboratory literature summary: Optimization of bivalent glutathione S-transferase inhibitors by combinatorial linker design
Peptide pharmacology
[Updated 2019 Jul 16]
US$ 27.50
US$ 21.04
US$ 21.16
US$ 28.73
US$ 21.38
US$ 26.42
